High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.

Cancer research - 1 Dec 1996

Man S, Ellis I O, Sibbering M, Blamey R W, Brook J D

Abstract excerpt

Fifty-four grade 1 tubular breast cancers and nine non-comedo ductal carcinoma in situ samples have been analyzed for loss of heterozygosity using a series of microsatellite markers. Markers mapping to regions of the genome for which loss of heterozygosity has been documented previously in higher...

Topics

Acid Anhydride Hydrolases
Adenocarcinoma
Alleles
Ataxia Telangiectasia Mutated Proteins
Breast Neoplasms
Carcinoma in Situ
Carcinoma, Ductal, Breast
Cell Cycle Proteins
Cell Transformation, Neoplastic
Chromosomes, Human
DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

DNA-Binding Proteins

Female

Gene Deletion

Heterozygote

Humans

Microsatellite Repeats

Neoplasm Invasiveness

Source

Open in PubMed

Identifiers

PMID: 8968105

Genes

ATM
FHIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8968105-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.PMID 8968105Read ↗

Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological featuresSemantic proximity Read ↗

Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.Semantic proximity Read ↗

Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer.Semantic proximity Read ↗

Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.Semantic proximity Read ↗

Loss of Heterozygosity Associated with Uniparental Disomy in Breast CarcinomaSemantic proximity Read ↗

Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.Semantic proximity Read ↗

PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue.Semantic proximity Read ↗

Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions.Semantic proximity Read ↗

Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast.Semantic proximity Read ↗

Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.Semantic proximity Read ↗

Loss of heterozygosity in bilateral breast cancer.Semantic proximity Read ↗

Loss of heterozygosity on chromosome XP22.2-p22.13 and Xq26.1-q27.1 in human breast carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.